Areas of Application
The technology provides a long-term
(for decades) storage of blood cells
to be used in clinical practice
Specifi cation
The technology enables storing human
donor blood cell (erythrocytes)
at a low temperature (–150÷–196 °C)
with Propanediosacharol as preservation
agent in disposable polymer cryocontainers
Stage of Development.
Suggestion for Commercialization
IRL5, TRL5
Preparation and transfer of technology
regulations, production and delivery
of special equipment to implement
freeze-thawing stages, and staff training,
upon request
Advantages
As compared with the known methods,
this technology has signifi cant advantages,
in particular, it facilitates the technological
stages of cell preparation for cryopreservation
and clinical application, it is notable
for a high level and stability of frozen cell
preservation and their clinical effectiveness,
is much cheaper and accessible for practical use
IPR Protection
IPR1, IPR3
For more information or to license this innovation:
- Log In
to view the innovation's details
- Sign Up
with discount code "ECOS"